TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – Khiron Life Sciences Corp., a Canadian integrated medical cannabis company with its core operations in Colombia, will welcome Colombia’s medical community as co-host of the inaugural International Medical Cannabis Symposium taking place Feb. 15 in Bogotá, Colombia.
Tag Archives: Khiron Life Sciences Corp.
TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Khiron Life Sciences Corp. reports that further to its press release dated September 26, 2017, the Company’s wholly owned subsidiary, Khiron Colombia SAS, has been granted all the licences required for the cultivation, production, domestic distribution and international export of both low and high tetrahydrocannabinol (“THC”) medical cannabis in the country of Colombia.
ORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.
TORONTO, Ontario, Sept. 26, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence ever issued by the Ministry of Justice for the cultivation of medical cannabis in Colombia.